{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:45:36Z","timestamp":1790109936879,"version":"4.0.1"},"reference-count":42,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2019.7548","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T17:07:07Z","timestamp":1557248827000},"source":"Crossref","is-referenced-by-count":11,"title":["Fluorofenidone affects hepatic stellate cell activation in hepatic fibrosis by targeting the TGF\u2011\u03b21\/Smad and MAPK signaling pathways"],"prefix":"10.3892","author":[{"given":"Yu","family":"Peng","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First People's Hospital of Changde City, Changde, Hunan 415000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Practice, The First People's Hospital of Lianyungang, Lianyungang, Jiangsu 222000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyan","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First People's Hospital of Changde City, Changde, Hunan 415000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congying","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endoscopy Center, Hunan Cancer Hospital, Changsha, Hunan 410000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Shen","sequence":"additional","affiliation":[{"name":"Institute of Medical Sciences, Xiangya Hospital, Central South University, Changsha, Hunan 410000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoyun","family":"Hu","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijian","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Nephropathy, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixiang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2019,5,6]]},"reference":[{"key":"key20200713100108_b1-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI200524282C1","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"key20200713100108_b2-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1002\/hep.20974","article-title":"Reversal of hepatic fibrosis e fact or fantasy?","author":"Friedman","year":"2006","journal-title":"Hepatology 43(2 Suppl 1)"},{"key":"key20200713100108_b3-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0168-8278(01)00142-8","article-title":"Oxidative stress-related molecules and liver fibrosis","volume":"35","author":"Parola","year":"2001","journal-title":"J Hepatol"},{"key":"key20200713100108_b4-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cbi.2015.08.013","article-title":"Chrysin attenuates liver fibrosis and hepatic stellate cell activation through TGF-b\/Smad signaling pathway","volume":"240","author":"Balta","year":"2015","journal-title":"Chem Biol Interact"},{"key":"key20200713100108_b5-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1136\/gut.46.5.593","article-title":"Hepatic regeneration and TGF-beta: Growing to a prosperous perfection","volume":"46","author":"Williams","year":"2000","journal-title":"Gut"},{"key":"key20200713100108_b6-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/cr.2009.5","article-title":"TGF-beta-induced epithelial to mesenchymal transition","volume":"19","author":"Xu","year":"2009","journal-title":"Cell Res"},{"key":"key20200713100108_b7-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1152\/ajpgi.00471.2012","article-title":"Fluorofenidone attenuates hepatic fibrosis by suppressing the proliferation and activation of hepatic stellate cells","volume":"306","author":"Peng","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"key20200713100108_b8-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/eci.12053","article-title":"The antihepatic fibrotic effects of fluorofenidone via MAPK signalling pathways","volume":"43","author":"Peng","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"key20200713100108_b9-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/MAJ.0000000000000501","article-title":"The protective mechanism of fluorofenidone in renal interstitial inflammation and fibrosis","volume":"350","author":"Tang","year":"2015","journal-title":"Am J Med Sci"},{"key":"key20200713100108_b10-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1111\/jcmm.12898","article-title":"Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1\u03b2\/IL-1R1\/MyD88\/NF-\u03baB pathway","volume":"20","author":"Song","year":"2016","journal-title":"J Cell Mol Med"},{"key":"key20200713100108_b11-etm-0-0-7548","first-page":"452","article-title":"Fluorofenidone inhibits transforming growth factor-beta1-induced cardiac myofibroblast differentiation","volume":"67","author":"Chen","year":"2012","journal-title":"Pharmazie"},{"key":"key20200713100108_b12-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: New tools for analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"},{"key":"key20200713100108_b13-etm-0-0-7548","first-page":"1087","article-title":"Chronic liver injury induced by immunologic reactions Cirrhosis following immunization with heterologous sera","volume":"49","author":"Paronetto","year":"1966","journal-title":"Am J Pathol"},{"key":"key20200713100108_b14-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1053\/gast.2001.21203","article-title":"Inhibition of the NA(+)\/H(+) exchanger reduces rat hepatic stellate cell activity and liver fibrosis: An in vitro and in vivo study","volume":"120","author":"Benedetti","year":"2001","journal-title":"Gastroenterology"},{"key":"key20200713100108_b15-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1053\/jhep.2003.50028","article-title":"Selective Na+\/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat","volume":"37","author":"Di Sario","year":"2003","journal-title":"Hepatology"},{"key":"key20200713100108_b16-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/hep.1840200213","article-title":"A histological semi-quantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: Comparison with morphometric studies","volume":"20","author":"Chevallier","year":"1994","journal-title":"Hepatology"},{"key":"key20200713100108_b17-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1021\/pr060644r","article-title":"Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer","volume":"6","author":"Pei","year":"2007","journal-title":"J Proteome Res"},{"key":"key20200713100108_b18-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1681\/ASN.2005070730","article-title":"Bone marrow-derived myofibroblasts contribute to the renal interstitial myofibroblast population and produce procollagen I after ischemia\/reperfusion in rats","volume":"18","author":"Broekema","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"key20200713100108_b19-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1006\/abio.1999.4085","article-title":"Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiacmyocytes in vitro","volume":"270","author":"Winer","year":"1999","journal-title":"Anal Biochem"},{"key":"key20200713100108_b20-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12967-016-1022-6","article-title":"Moniliformediquinone as a potential therapeutic agent, inactivation of hepatic stellate cell and inhibition of liver fibrosis in vivo","volume":"14","author":"Tsui","year":"2016","journal-title":"J Transl Med"},{"key":"key20200713100108_b21-etm-0-0-7548","article-title":"Liver Pathology","author":"Ferrell","year":"2011"},{"key":"key20200713100108_b22-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.intimp.2018.09.021","article-title":"Lisinopril inhibits nuclear transcription factor kappa B and augments sensitivity to silymarin in experimental liver fibrosis","volume":"64","author":"Saber","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"key20200713100108_b23-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.fct.2010.12.006","article-title":"Effects of standardized bilberry fruit extract (Mirtoselect\u00ae) on resolution of CCl4-induced liver fibrosis in mice","volume":"49","author":"Domitrovi\u0107","year":"2011","journal-title":"Food Chem Toxicol"},{"key":"key20200713100108_b24-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1365-2893.2008.00971.x","article-title":"Effects of silymarin on the resolution of liver fibrosis induced by carbon tetrachloride in rats","volume":"15","author":"Tsai","year":"2008","journal-title":"J Viral Hepat"},{"key":"key20200713100108_b25-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"key20200713100108_b26-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biochi.2014.10.013","article-title":"Hypoxia-inducible factor-1alpha in hepatic fibrosis: A promising therapeutic target","volume":"108","author":"Zhan","year":"2015","journal-title":"Biochimie"},{"key":"key20200713100108_b27-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1111\/liv.12638","article-title":"Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT\/mTOR\/p70S6K and TGFb\/Smad signalling pathways","volume":"35","author":"Li","year":"2015","journal-title":"Liver Int"},{"key":"key20200713100108_b28-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.biochi.2015.03.015","article-title":"Effects of geniposide on hepatocytes undergoing epitheliale-mesenchymal transition in hepatic fibrosis by targeting TGFb\/Smad and ERK-MAPK signaling pathways","volume":"113","author":"Park","year":"2015","journal-title":"Biochimie"},{"key":"key20200713100108_b29-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejphar.2016.04.042","article-title":"Isorhamnetin attenuates liver fibrosis by inhibiting TGF-\u03b2\/Smad signaling and relieving oxidative stress","volume":"783","author":"Yang","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"key20200713100108_b30-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1074\/jbc.275.4.2247","article-title":"Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury","volume":"275","author":"Friedman","year":"2000","journal-title":"J Biol Chem"},{"key":"key20200713100108_b31-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/labinvest.3700094","article-title":"Dominant-negative soluble PDGF-beta receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis","volume":"84","author":"Borkham-Kamphorst","year":"2004","journal-title":"Lab Invest"},{"key":"key20200713100108_b32-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/jhep.2002.30083","article-title":"Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury","volume":"35","author":"Tahashi","year":"2002","journal-title":"Hepatology"},{"key":"key20200713100108_b33-etm-0-0-7548","first-page":"41","article-title":"Stellate cells","author":"Marra","year":"2010"},{"key":"key20200713100108_b34-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/ncpgasthep0055","article-title":"Mechanisms of disease: Mechanismsofhepatic fibrosis and therapeutic implications","volume":"1","author":"Friedman","year":"2004","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"key20200713100108_b35-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1042\/BST0350661","article-title":"TGF-beta, Smad3 and the process of progressive fibrosis","volume":"35","author":"Gauldie","year":"2007","journal-title":"Biochem Soc Trans"},{"key":"key20200713100108_b36-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1111\/j.1440-1746.2006.04659.x","article-title":"Molecular mechanisms of hepatic fibrogenesis","volume":"22","author":"Parsons","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"key20200713100108_b37-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1146\/annurev.cellbio.21.022404.142018","article-title":"Specificity and versatility in tgf-beta signaling through smads","volume":"21","author":"Feng","year":"2005","journal-title":"Annu Rev Cell Dev Biol"},{"key":"key20200713100108_b38-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.bbrc.2006.12.035","article-title":"Snail is required for transforming growth factor-beta-induced epithelial-mesenchymal transition by activating PI3 kinase\/Akt signal pathway","volume":"353","author":"Cho","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200713100108_b39-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00018-010-0514-4","article-title":"Smad linker region phosphorylation in the regulation of extracellular matrix synthesis","volume":"68","author":"Burch","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"key20200713100108_b40-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"12546","DOI":"10.1021\/bi050560g","article-title":"Identification and characterization of ERK MAP kinase phosphorylation sites in Smad3","volume":"44","author":"Matsuura","year":"2005","journal-title":"Biochemistry"},{"key":"key20200713100108_b41-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.bcp.2014.09.022","article-title":"Myricetin inhibits advanced glycation end product (AGE)-induced migration of retinal pericytes through phosphorylation of ERK1\/2, FAK-1, and paxillin in vitro and in vivo","volume":"93","author":"Kim","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"key20200713100108_b42-etm-0-0-7548","doi-asserted-by":"publisher","first-page":"G974","DOI":"10.1152\/ajpgi.00264.2003","article-title":"TGF-beta1 modulates matrix metalloproteinase-13 expression in hepatic stellate cells by complex mechanisms involving p38MAPK, PI3-kinase, AKT, and p70S6k","volume":"287","author":"Lechuga","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T09:01:22Z","timestamp":1594630882000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2019.7548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,6]]},"references-count":42,"URL":"https:\/\/doi.org\/10.3892\/etm.2019.7548","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,6]]}}}